Alliances

Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH announce a drug discovery collaboration on an undisclosed G-protein coupled receptor.

Reston Hospital Center and Children’s National Health System in Washington, D.C. officially launched their strategic partnership to enhance the neonatology services at RHC on July 1, 2019.

Agreement will cover development and marketing of oncolytic virotherapies

Companies from across the globe provide information on agreements and pipeline updates.

Under the agreement, Thermo Fisher will provide Amicus with immediate clinical and commercial manufacturing capabilities and capacity for Amicus’ intrathecal AAV Batten disease gene therapy programs.

Draper, based in Cambridge, Massachusetts, signed a tissue model development deal with Bristol-Myers Squibb. The companies will collaborate on developing a unique liver tissue model to screen drugs for toxicity.

Vivoryon Therapeutics AG, announced that they have entered into a research collaboration with University Medical Center Schleswig-Holstein, Campus Kiel, to discover and develop first-in-class therapeutics in cancer immunotherapy.

Biotech and pharma companies from across the globe share pipeline and business updates.

Amarantus Bioscience Holdings, Inc. announced that it has entered into a Letter of Intent with The Alchemist’s Kitchen, a plant-based wellness company marketing the Plant Alchemy brand of health and wellness products, to establish a joint venture for commercialization of hemp based herbal smokable products ‘Herbal Smokes’ in addition to conducting research for cannabinoid derived addiction treatment, including smoking cessation, and other indications such as insomnia.

GENFIT announced the signing of a licensing and collaboration agreement with Terns Pharmaceuticals, a global biopharmaceutical company based in the U.S. and China with a focus on developing novel and combination therapies to treat liver disease.